Cardiometabolic Disorders News

Adults who initiated once-weekly semaglutide after not responding to bariatric surgery lost a similar amount of weight as those without a history of bariatric surgery, according to study findings published in Obesity.

The SELECT trial, which showed semaglutide, a GLP-1 receptor agonist also approved for diabetes, reduced CV events in people with overweight/obesity and CVD but no diabetes, was one of the most important developments in cardiology in 2023.

PHILADELPHIA — Two common reproductive health conditions, dysmenorrhea and polycystic ovary syndrome, are associated with increasing CVD risk in women, according to research presented at the American Heart Association Scientific Sessions.

Adolescents and young adults who exercise for a longer duration per day, even if it is light physical activity, can reduce their fat mass, according to a study published in Nature Communications.

Young adults who consumed tree nuts as snacks had a lower risk for metabolic syndrome than those who did not, as well as improvements in waist circumference, visceral fat and blood insulin levels, a study found.

For women experiencing disruptive, bothersome hot flashes, the use of menopausal hormone therapy — a one-time standard but later feared treatment option — is far from straightforward.

PHILADELPHIA — In the EMPA-ICD trial, patients with type 2 diabetes and an implantable cardioverter defibrillator had fewer ventricular arrhythmias at 24 weeks when assigned empagliflozin compared with placebo.

Adolescents and young adults who partake in more light physical activity have lower cholesterol levels, according to a study published in The Journal of Clinical Endocrinology & Metabolism.

Findings from two cardiovascular outcome trials revealed that targeting obesity could become a major focus for treating cardiovascular disease and heart failure with preserved ejection fraction in the future, according to a speaker.

Promising new devices and emerging drug classes may improve BP control for some patients with difficult-to-treat hypertension, but clinicians must first address the structural inequities that impact access to care, according to a speaker.